101 related articles for article (PubMed ID: 24468012)
1. A comparison of methylation levels in HPV18, HPV31 and HPV33 genomes reveals similar associations with cervical precancers.
Vasiljević N; Scibior-Bentkowska D; Brentnall A; Cuzick J; Lorincz A
J Clin Virol; 2014 Mar; 59(3):161-6. PubMed ID: 24468012
[TBL] [Abstract][Full Text] [Related]
2. Methylation of HPV18, HPV31, and HPV45 genomes and cervical intraepithelial neoplasia grade 3.
Wentzensen N; Sun C; Ghosh A; Kinney W; Mirabello L; Wacholder S; Shaber R; LaMere B; Clarke M; Lorincz AT; Castle PE; Schiffman M; Burk RD
J Natl Cancer Inst; 2012 Nov; 104(22):1738-49. PubMed ID: 23093560
[TBL] [Abstract][Full Text] [Related]
3. HPV33 DNA methylation measurement improves cervical pre-cancer risk estimation of an HPV16, HPV18, HPV31 and \textit{EPB41L3} methylation classifier.
Brentnall AR; Vasiljevic N; Scibior-Bentkowska D; Cadman L; Austin J; Cuzick J; Lorincz AT
Cancer Biomark; 2015; 15(5):669-75. PubMed ID: 26406956
[TBL] [Abstract][Full Text] [Related]
4. A DNA methylation classifier of cervical precancer based on human papillomavirus and human genes.
Brentnall AR; Vasiljević N; Scibior-Bentkowska D; Cadman L; Austin J; Szarewski A; Cuzick J; Lorincz AT
Int J Cancer; 2014 Sep; 135(6):1425-32. PubMed ID: 24535756
[TBL] [Abstract][Full Text] [Related]
5. Virtues and Weaknesses of DNA Methylation as a Test for Cervical Cancer Prevention.
Lorincz AT
Acta Cytol; 2016; 60(6):501-512. PubMed ID: 27806357
[TBL] [Abstract][Full Text] [Related]
6. Methylation of High-Risk Human Papillomavirus Genomes Are Associated with Cervical Precancer in HIV-Positive Women.
Gradissimo A; Lam J; Attonito JD; Palefsky J; Massad LS; Xie X; Eltoum IE; Rahangdale L; Fischl MA; Anastos K; Minkoff H; Xue X; D'Souza G; Flowers LC; Colie C; Shrestha S; Hessol NA; Strickler HD; Burk RD
Cancer Epidemiol Biomarkers Prev; 2018 Dec; 27(12):1407-1415. PubMed ID: 30237251
[TBL] [Abstract][Full Text] [Related]
7. Quantitative measurement of Human Papillomavirus type 16 L1/L2 DNA methylation correlates with cervical disease grade.
Bryant D; Tristram A; Liloglou T; Hibbitts S; Fiander A; Powell N
J Clin Virol; 2014 Jan; 59(1):24-9. PubMed ID: 24268385
[TBL] [Abstract][Full Text] [Related]
8. Human Papillomavirus 16, 18, 31 and 45 viral load, integration and methylation status stratified by cervical disease stage.
Marongiu L; Godi A; Parry JV; Beddows S
BMC Cancer; 2014 May; 14():384. PubMed ID: 24885011
[TBL] [Abstract][Full Text] [Related]
9. Evolution and taxonomic classification of human papillomavirus 16 (HPV16)-related variant genomes: HPV31, HPV33, HPV35, HPV52, HPV58 and HPV67.
Chen Z; Schiffman M; Herrero R; Desalle R; Anastos K; Segondy M; Sahasrabuddhe VV; Gravitt PE; Hsing AW; Burk RD
PLoS One; 2011; 6(5):e20183. PubMed ID: 21673791
[TBL] [Abstract][Full Text] [Related]
10. Human papillomavirus type 16 L1/L2 DNA methylation shows weak association with cervical disease grade in young women.
Bryant D; Hibbitts S; Almonte M; Tristram A; Fiander A; Powell N
J Clin Virol; 2015 May; 66():66-71. PubMed ID: 25866341
[TBL] [Abstract][Full Text] [Related]
11. Human Papillomavirus DNA Methylation as a Biomarker for Cervical Precancer: Consistency across 12 Genotypes and Potential Impact on Management of HPV-Positive Women.
Clarke MA; Gradissimo A; Schiffman M; Lam J; Sollecito CC; Fetterman B; Lorey T; Poitras N; Raine-Bennett TR; Castle PE; Wentzensen N; Burk RD
Clin Cancer Res; 2018 May; 24(9):2194-2202. PubMed ID: 29420222
[No Abstract] [Full Text] [Related]
12. Human papillomavirus DNA methylation as a potential biomarker for cervical cancer.
Clarke MA; Wentzensen N; Mirabello L; Ghosh A; Wacholder S; Harari A; Lorincz A; Schiffman M; Burk RD
Cancer Epidemiol Biomarkers Prev; 2012 Dec; 21(12):2125-37. PubMed ID: 23035178
[TBL] [Abstract][Full Text] [Related]
13. Bayesian analysis of baseline risk of CIN2 and ≥CIN3 by HPV genotype in a European referral cohort.
Bonde J; Bottari F; Parvu V; Pedersen H; Yanson K; Iacobone AD; Kodsi S; Landoni F; Vaughan L; Ejegod DM; Sandri MT
Int J Cancer; 2019 Aug; 145(4):1033-1041. PubMed ID: 30895602
[TBL] [Abstract][Full Text] [Related]
14. Assessment of viral methylation levels for high risk HPV types by newly designed consensus primers PCR and pyrosequencing.
Gillio-Tos A; Fiano V; Grasso C; Trevisan M; Gori S; Mongia A; De Marco L; Ronco G;
PLoS One; 2018; 13(3):e0194619. PubMed ID: 29579066
[TBL] [Abstract][Full Text] [Related]
15. HPV genotype distribution and anomalous association of HPV33 to cervical neoplastic lesions in San Luis Potosí, Mexico.
DelaRosa-Martínez R; Sánchez-Garza M; López-Revilla R
Infect Agent Cancer; 2016; 11():16. PubMed ID: 27030798
[TBL] [Abstract][Full Text] [Related]
16. Different DNA methylation pattern of HPV16, HPV18 and HPV51 genomes in asymptomatic HPV infection as compared to cervical neoplasia.
Simanaviciene V; Popendikyte V; Gudleviciene Z; Zvirbliene A
Virology; 2015 Oct; 484():227-233. PubMed ID: 26119875
[TBL] [Abstract][Full Text] [Related]
17. Type-dependent integration frequency of human papillomavirus genomes in cervical lesions.
Vinokurova S; Wentzensen N; Kraus I; Klaes R; Driesch C; Melsheimer P; Kisseljov F; Dürst M; Schneider A; von Knebel Doeberitz M
Cancer Res; 2008 Jan; 68(1):307-13. PubMed ID: 18172324
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of genotype-specific human papillomavirus infection and cervical neoplasia in Taiwan: a community-based survey of 10,602 women.
Chen HC; You SL; Hsieh CY; Schiffman M; Lin CY; Pan MH; Chou YC; Liaw KL; Hsing AW; Chen CJ;
Int J Cancer; 2011 Mar; 128(5):1192-203. PubMed ID: 20853317
[TBL] [Abstract][Full Text] [Related]
19. Methylation of human papillomavirus-52 and -58 is a candidate biomarker in cervical neoplasia.
Murakami I; Fujii T; Dan K; Saito M; Ohno A; Iwata T; Aoki D
J Clin Virol; 2013 Sep; 58(1):149-54. PubMed ID: 23871162
[TBL] [Abstract][Full Text] [Related]
20. The effectiveness of HPV16 and HPV18 genotyping and cytology with different thresholds for the triage of human papillomavirus-based screening on self-collected samples.
Song F; Du H; Wang C; Huang X; Wu R;
PLoS One; 2020; 15(6):e0234518. PubMed ID: 32525936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
